← Back to Search

Hormone Therapy

Oxytocin for Alcoholism

Phase 2
Waitlist Available
Led By Jennifer Mitchell, PhD
Research Sponsored by Jennifer Mitchell
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up ~ 90 minutes post study drug administration
Awards & highlights

Study Summary

This study is evaluating whether oxytocin may have positive impacts for individuals with alcohol use disorder.

Eligible Conditions
  • Alcoholism

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~~ 90 minutes post study drug administration
This trial's timeline: 3 weeks for screening, Varies for treatment, and ~ 90 minutes post study drug administration for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Alcohol cue craving score
Image approach task

Trial Design

2Treatment groups
Experimental Treatment
Group I: Placebo FirstExperimental Treatment2 Interventions
Subjects will receive placebo prior to their first scanning session, and oxytocin prior to their second scanning session.
Group II: Oxytocin FirstExperimental Treatment2 Interventions
Subjects will receive oxytocin prior to their first scanning session, and placebo prior to their second scanning session.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Placebo
1995
Completed Phase 3
~2670
Oxytocin
2016
Completed Phase 4
~2340

Find a Location

Who is running the clinical trial?

Jennifer MitchellLead Sponsor
2 Previous Clinical Trials
125 Total Patients Enrolled
2 Trials studying Alcoholism
125 Patients Enrolled for Alcoholism
Jennifer Mitchell, PhDPrincipal InvestigatorUniversity of California, San Francisco
3 Previous Clinical Trials
187 Total Patients Enrolled
1 Trials studying Alcoholism
62 Patients Enrolled for Alcoholism

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~0 spots leftby Apr 2025